x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
DELAWARE
|
22-1642321
|
(State
or Other Jurisdiction of
|
(I.R.S.
Employer
|
Incorporation
or Organization)
|
Identification
No.)
|
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller
reporting company x
|
Page
|
||
PART I. |
FINANCIAL
INFORMATION
|
|
Item
1.
|
Financial
Statements
|
|
Consolidated
Statements of Operations and Comprehensive Income (Loss)
|
||
for
the Quarters Ended March 29, 2008
|
||
and
March 31, 2007 (Unaudited)
|
1
|
|
Consolidated
Balance Sheets-March 29, 2008 (Unaudited) and
|
||
December
29, 2007
|
2
|
|
Consolidated
Statement of Stockholders’ Equity for the Quarter
|
||
Ended
March 29, 2008 (Unaudited)
|
3
|
|
Consolidated
Statements of Cash Flows for the Quarters
|
||
Ended
March 29, 2008 and March 31, 2007 (Unaudited)
|
4
|
|
Notes
to Consolidated Financial Statements
|
5
|
|
Item
2.
|
Management's
Discussion and Analysis of Financial Condition
|
|
and
Results of Operations
|
14
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
23
|
Item
4.
|
Controls
and Procedures
|
23
|
PART
II.
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
23
|
Item
1A.
|
Risk
Factors
|
23
|
Item
5.
|
Other
Information
|
24
|
Item
6.
|
Exhibits
|
24
|
Signatures
|
25
|
Quarters
Ended
|
|||||||
March
29,
|
March
31,
|
||||||
2008
|
2007
|
||||||
CONTINUING
OPERATIONS
|
|||||||
Net
sales
|
$
|
5,757,686
|
$
|
4,511,446
|
|||
Costs
and expenses:
|
|||||||
Cost
of sales
|
3,451,960
|
2,814,120
|
|||||
Selling,
general and administrative
|
2,244,570
|
2,217,002
|
|||||
Research
and development
|
372,818
|
484,245
|
|||||
6,069,348
|
5,515,367
|
||||||
Operating
loss
|
(311,662
|
)
|
(1,003,921
|
)
|
|||
Interest
and other (expense) income, net
|
(60,573
|
)
|
20,632
|
||||
Loss
from continuing operations before income taxes
|
(372,235
|
)
|
(983,289
|
)
|
|||
Provision
for income taxes
|
-
|
-
|
|||||
Loss
from continuing operations
|
(372,235
|
)
|
(983,289
|
)
|
|||
DISCONTINUED
OPERATIONS
|
|||||||
Loss
from discontinued operations
|
-
|
(280,513
|
)
|
||||
Net
loss
|
$
|
(372,235
|
)
|
$
|
(1,263,802
|
)
|
|
Loss
per common share from continuing operations-basic and
diluted
|
$
|
(.13
|
)
|
$
|
(.32
|
)
|
|
Loss
per common share from discontinued operations-basic and
diluted
|
$
|
-
|
$
|
(.09
|
)
|
||
Net
loss per common share-basic and diluted
|
$
|
(.13
|
)
|
$
|
(.41
|
)
|
|
Weighted
average number of shares outstanding-basic and diluted
|
2,932,521
|
3,096,315
|
|||||
COMPREHENSIVE
INCOME (LOSS)
|
|||||||
Net
loss
|
$
|
(372,235
|
)
|
$
|
(1,263,802
|
)
|
|
Other
comprehensive income:
|
|||||||
Foreign
currency translation adjustment
|
-
|
61,383
|
|||||
Comprehensive
loss
|
$
|
(372,235
|
)
|
$
|
(1,202,419
|
)
|
March 29,
|
December 29,
|
||||||
2008
|
2007
|
||||||
|
(UNAUDITED)
|
(Note
1)
|
|||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
626,882
|
$
|
2,004,471
|
|||
Accounts
receivable, net
|
5,796,735
|
5,299,753
|
|||||
Inventories,
net
|
6,074,147
|
5,039,770
|
|||||
Other
current assets
|
741,803
|
774,007
|
|||||
Due
from assets sale contract
|
-
|
664,282
|
|||||
Total
current assets
|
13,239,567
|
13,782,283
|
|||||
Property,
plant and equipment
|
37,863,621
|
37,556,672
|
|||||
Less
accumulated depreciation and amortization
|
27,173,685
|
26,600,240
|
|||||
Property,
plant and equipment, net
|
10,689,936
|
10,956,432
|
|||||
Restricted
cash
|
-
|
250,000
|
|||||
Other
assets
|
539,117
|
531,633
|
|||||
Deferred
tax assets
|
52,000
|
52,000
|
|||||
Total
Assets
|
$
|
24,520,620
|
$
|
25,572,348
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Current
portion of long-term debt
|
$
|
550,000
|
$
|
550,000
|
|||
Accounts
payable
|
976,371
|
943,381
|
|||||
Accrued
liabilities
|
1,461,746
|
1,965,403
|
|||||
Customer
deposits
|
346,272
|
363,296
|
|||||
Deferred
income taxes
|
52,000
|
52,000
|
|||||
Total
current liabilities
|
3,386,389
|
3,874,180
|
|||||
Long-term
debt, net of current portion
|
3,375,000
|
3,762,500
|
|||||
Deferred
liabilities
|
62,038
|
61,300
|
|||||
Total
liabilities
|
6,823,427
|
7,697,980
|
|||||
Commitments
and contingencies Stockholders' equity:
|
|||||||
Preferred
stock, par value $.01 per share: Authorized: 1,000,000 shares No
shares
issued
|
|||||||
Common
stock, par value $.01 per share: 20,000,000 shares authorized; 3,300,289
and 3,289,103 shares issued; and 2,937,384 and 2,926,198 shares
outstanding, respectively
|
33,003
|
32,891
|
|||||
Additional
paid-in capital
|
19,984,665
|
19,789,717
|
|||||
Retained
earnings
|
801,689
|
1,173,924
|
|||||
20,819,357
|
20,996,532
|
||||||
Less
treasury stock, at cost – 362,905 shares at March 29, 2008 and
December 29, 2007
|
(3,122,164
|
)
|
(3,122,164
|
)
|
|||
Total
stockholders' equity
|
17,697,193
|
17,874,368
|
|||||
Total
Liabilities and Stockholders' Equity
|
$
|
24,520,620
|
$
|
25,572,348
|
Additional
|
||||||||||||||||||||||
Common Stock
|
Paid-in
|
Retained
|
Treasury Stock
|
|||||||||||||||||||
Shares
|
Amount
|
Capital(A)
|
Earnings
|
Shares
|
Amount
|
Total
|
||||||||||||||||
Balance,
December 29, 2007
|
3,289,103
|
$
|
32,891
|
$
|
19,789,717
|
$
|
1,173,924
|
362,905
|
$
|
(3,122,164
|
)
|
$
|
17,874,368
|
|||||||||
Net
loss
|
(372,235
|
)
|
(372,235
|
)
|
||||||||||||||||||
Share-based
compensation
|
120,346
|
|
120,346
|
|||||||||||||||||||
Stock
Purchase Plan sales
|
7,104
|
71
|
46,312
|
46,383
|
||||||||||||||||||
Exercise
of stock options
|
4,082
|
41
|
28,290
|
28,331
|
||||||||||||||||||
Balance,
March 29, 2008
|
3,300,289
|
$
|
33,003
|
$
|
19,984,665
|
$
|
801,689
|
362,905
|
$
|
(3,122,164
|
)
|
$
|
17,697,193
|
Quarters Ended
|
|||||||
March 29, 2008
|
March 31, 2007
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(372,235
|
)
|
$
|
(1,263,802
|
)
|
|
Less
loss from discontinued operations
|
-
|
(280,513
|
)
|
||||
Loss
from continuing operations
|
(372,235
|
)
|
(983,289
|
)
|
|||
Adjustments
to reconcile net loss from continuing operations to net cash provided
by
(used in) operating activities:
|
|||||||
Depreciation
and amortization
|
618,341
|
571,361
|
|||||
Amortization
of deferred financing costs
|
8,040
|
7,196
|
|||||
Share-based
compensation
|
120,346
|
51,461
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
(496,982
|
)
|
1,023,611
|
||||
Inventories
|
(1,034,377
|
)
|
(174,565
|
)
|
|||
Other
current assets
|
32,203
|
246,076
|
|||||
Other
assets
|
(15,524
|
)
|
17,297
|
||||
Accounts
payable
|
32,890
|
(131,595
|
)
|
||||
Accrued
liabilities
|
(503,656
|
)
|
47,631
|
||||
Customer
deposits
|
(17,024
|
)
|
(14,229
|
)
|
|||
Deferred
liabilities
|
738
|
5,865
|
|||||
Net
cash provided by (used in) operating activities of continuing
operations
|
(1,627,240
|
) |
666,820
|
||||
Net
cash used in operating activities of discontinued
operations
|
-
|
(151,911
|
)
|
||||
Net
cash provided by (used in) operating activities
|
(1,627,240
|
)
|
514,909
|
||||
Cash
flows from investing activities:
|
|||||||
Purchases
of capital assets
|
(351,845
|
)
|
(400,524
|
)
|
|||
Cash
proceeds from sale of discontinued operations
|
664,282
|
-
|
|||||
Net
cash provided by (used in) investing activities of continuing
operations
|
312,437
|
(400,524
|
)
|
||||
Net
cash used in investing activities of discontinued
operations
|
-
|
(98,202
|
)
|
||||
Net
cash provided by (used in) investing activities
|
312,437
|
(498,726
|
)
|
||||
Cash
flows from financing activities:
|
|||||||
Repurchase
of common stock for the treasury
|
-
|
(2,148,300
|
)
|
||||
Repayment
of borrowings
|
(387,500
|
)
|
(137,500
|
)
|
|||
Restricted
cash returned
|
250,000
|
-
|
|||||
Proceeds
from the exercise of stock options
|
28,331
|
43,750
|
|||||
Proceeds
from Stock Purchase Plan sales
|
46,383
|
7,495
|
|||||
Net
cash used in financing activities of continuing
operations
|
(62,786
|
)
|
(2,234,555
|
)
|
|||
Net
cash used in financing activities of discontinued
operations
|
-
|
(43,010
|
)
|
||||
Net
cash used in financing activities
|
(62,786
|
)
|
(2,277,565
|
)
|
|||
Effect
of exchange rate changes on cash
|
-
|
2,327
|
|||||
Net
decrease in cash and cash equivalents
|
(1,377,589
|
)
|
(2,259,055
|
)
|
|||
Cash
and cash equivalents at beginning of period, including $0 and $562,205
reported under assets held for sale
|
2,004,471
|
5,961,538
|
|||||
Cash
and cash equivalents at end of period including $0 and $271,409 reported
under assets held for sale
|
$
|
626,882
|
$
|
3,702,483
|
|||
Supplemental
disclosures of cash flow information:
|
|||||||
Cash
paid during the period for interest
on credit facilities
|
$
|
62,044
|
$
|
91,341
|
Quarter ended
March 31,
2007
|
||||
Net
sales
|
$
|
925,674
|
||
Net
loss
|
$
|
(280,513
|
)
|
Quarters Ended
|
|||||||
March 29, 2008
|
March 31, 2007
|
||||||
|
|
||||||
Cost
of sales
|
$
|
45,000
|
$
|
8,000
|
|||
Selling,
general and administrative
|
75,000
|
43,000
|
|||||
Total
share-based compensation
|
$
|
120,000
|
$
|
51,000
|
2008
|
|||||||
Weighted
|
|||||||
average
|
Shares
|
||||||
exercise
|
or
price
|
||||||
price
|
per
share
|
||||||
Outstanding
at beginning of year
|
$
|
9.30
|
594,747
|
||||
Granted
|
-
|
-
|
|||||
Exercised
|
6.94
|
(4,082
|
)
|
||||
Expired
|
8.46
|
(23,785
|
)
|
||||
Forfeited
|
11.29
|
(58,500
|
)
|
||||
Outstanding
at end of period
|
9.32
|
508,380
|
|||||
Exercisable
at end of period
|
$
|
9.20
|
222,647
|
||||
Option
price range at end of period
|
|
$3.10-$17.00
|
|||||
Weighted
average estimated fair value of options granted during the
year
|
$
|
-
|
Aggregate
intrinsic value of all options at March 29, 2008
|
$
|
65,000
|
||
Aggregate
intrinsic value of exercisable options at March 29, 2008
|
$
|
65,000
|
||
Intrinsic
value of options exercised during 2008
|
$
|
9,000
|
Weighted-
|
|||||||
Average
|
|||||||
Grant-Day
|
|||||||
Fair
Value
|
Shares
|
||||||
Outstanding
at December 29, 2007
|
$
|
9.69
|
16,500
|
||||
Granted
|
-
|
-
|
|||||
Vested
|
-
|
-
|
|||||
Outstanding
at March 29, 2008
|
$
|
9.69
|
16,500
|
March 29,
2008
|
December 29,
2007
|
||||||
Finished
goods
|
$
|
278,096
|
$
|
239,503
|
|||
Work
in process
|
3,684,579
|
2,979,632
|
|||||
Raw
materials and purchased parts
|
2,111,472
|
1,820,635
|
|||||
Total
|
$
|
6,074,147
|
$
|
5,039,770
|
2008
|
2007
|
||||||
Capital
One, N.A.:
|
|||||||
Revolving
line of credit, 2.00% above LIBOR or 0.50% below prime
|
$
|
-
|
$
|
-
|
|||
Term
loan, due October 1, 2011, 2.25% above LIBOR or 0.50% below
prime
|
1,400,000
|
1,500,000
|
|||||
Mortgage
loan, due October 1, 2016, 2.25% above LIBOR or 0.50% below
prime
|
2,525,000
|
2,812,500
|
|||||
3,925,000
|
4,312,500
|
||||||
Less
current portion
|
550,000
|
550,000
|
|||||
Long-term
portion
|
$
|
3,375,000
|
$
|
3,762,500
|
March 31,
2007
|
||||
|
||||
Net
sales
|
$
|
926,000
|
||
Net
loss
|
$
|
(281,000
|
)
|
Net
assets:
|
||||
Property,
plant and equipment, at cost
|
$
|
14,851,000
|
||
Less
accumulated depreciation and amortization
|
9,706,000
|
|||
Property,
plant and equipment, net
|
5,145,000
|
|||
Inventories
|
488,000
|
|||
Other
assets, net
|
144,000
|
|||
Total
net assets at March 29, 2008
|
5,777,000
|
|||
Commitments:
|
||||
Planned
equipment purchases for the remainder of 2008
|
625,000
|
|||
Lease
obligations through January 2011
|
550,000
|
|||
Total
commitments
|
1,175,000
|
|||
Total
net assets and commitments
|
$
|
6,952,000
|
· |
declines
in the market value of inventory;
|
· |
changes
in customer demand for inventory, such as cancellation of orders;
and
|
· |
our
purchases of inventory beyond customer needs that result in excess
quantities on hand that may not be returned to the vendor or charged
back
to the customer.
|
Percentage of Net Sales
|
|||||||
Quarters
Ended
|
|||||||
March 29,
|
March 31,
|
||||||
Continuing
operations
|
2008
|
2007
|
|||||
Net
sales
|
100.0
|
%
|
100.0
|
%
|
|||
Costs
and expenses:
|
|||||||
Cost
of sales
|
60.0
|
62.4
|
|||||
Selling,
general and administrative
|
39.0
|
49.2
|
|||||
Research
and development
|
6.4
|
10.7
|
|||||
105.4
|
122.3
|
||||||
Operating
loss
|
(5.4
|
)
|
(22.3
|
)
|
|||
Interest
and other (expense) income, net
|
(1.1
|
)
|
0.5
|
||||
Loss
from continuing operations before income taxes
|
(6.5
|
)
|
(21.8
|
)
|
|||
Provision
for income taxes
|
-
|
-
|
|||||
Loss
from continuing operations
|
(6.5
|
)
|
(21.8
|
)
|
|||
Loss
from discontinued operations
|
-
|
(6.2
|
)
|
||||
Net
loss
|
(6.5
|
)%
|
(28.0
|
)%
|
2008
|
2007
|
||||||
Beginning
backlog
|
$
|
17,991,000
|
$
|
11,490,000
|
|||
Plus
orders
|
8,155,000
|
5,969,000
|
|||||
Less
net sales
|
5,758,000
|
4,511,000
|
|||||
Ending
backlog
|
$
|
20,388,000
|
$
|
12,948,000
|
|||
Book-to-bill
ratio
|
1.42
|
1.32
|
Quarter ended March 29, 2008
|
Quarter ended March 31, 2007
|
||||||||||||||||||
$
|
Increase/
(Decrease)
from prior
period
|
% of
Net Sales
|
$
|
Increase/
(Decrease)
from prior
period
|
% of
Net Sales
|
||||||||||||||
Consolidated
gross profit
|
$
|
2,306,000
|
$
|
609,000
|
40.0
|
%
|
$
|
1,697,000
|
$
|
(171,000
|
)
|
37.6
|
%
|
EXHIBIT
NUMBER
|
DESCRIPTION
OF EXHIBIT
|
|
31.1+
|
Chief
Executive Officer's Certificate, pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
31.2+
|
Chief
Financial Officer's Certificate, pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
32.1+
|
Chief
Executive Officer's Certificate, pursuant to 18 U.S.C. Section 1350,
as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
|
32.2+
|
Chief
Financial Officer's Certificate, pursuant to 18 U.S.C. Section 1350,
as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
Date:
May 13, 2008
|
By:
|
/s/
Mason N. Carter
|
Mason
N. Carter
|
||
Chairman,
President and
|
||
Chief
Executive Officer
|
Date:
May 13, 2008
|
By:
|
/s/
Robert V. Condon
|
Robert
V. Condon
|
||
Vice
President, Finance and
|
||
Chief
Financial Officer
|